Isaac E. Ciechanover
2017
In 2017, Isaac E. Ciechanover earned a total compensation of $3.4M as President and Chief Executive Officer at Atara Biotherapeutics, a 66% decrease compared to previous year.
Compensation breakdown
| Bonus | $320,503 |
|---|---|
| Salary | $562,380 |
| Stock Awards | $2,483,250 |
| Other | $689 |
| Total | $3,366,822 |
Ciechanover received $2.5M in stock awards, accounting for 74% of the total pay in 2017.
Ciechanover also received $320.5K in bonus, $562.4K in salary and $689 in other compensation.
Rankings
In 2017, Isaac E. Ciechanover's compensation ranked 3,157th out of 14,666 executives tracked by ExecPay. In other words, Ciechanover earned more than 78.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,157 out of 14,666 | 79th |
Division Manufacturing | 1,085 out of 5,772 | 81st |
Major group Chemicals And Allied Products | 298 out of 2,075 | 86th |
Industry group Drugs | 228 out of 1,731 | 87th |
Industry Biological Products, Except Diagnostic Substances | 44 out of 313 | 86th |
Source: SEC filing on April 26, 2018.
Ciechanover's colleagues
We found two more compensation records of executives who worked with Isaac E. Ciechanover at Atara Biotherapeutics in 2017.